Table 2.
Transgenic modification | Promotor | Anatomical site | Prevalence | Onset (months) | Reference |
---|---|---|---|---|---|
Spontaneous models | |||||
E6/E7/mrasR12 | K14 | OC | 100 | 3–4 | [44] |
KrasG12/TP53del/del | K14 | T | 100 | < 1 | [45] |
KrasG12/KLF4del/del | K14 | T | 21 | < 1 | [46] |
KrasG12/SMAD4wt/del | K14 | OC | n.a. | 3–4 | [47] |
SMAD4del/del | K14 | OC | 74 | 10 | [47] |
4NQO-induced models | |||||
GRHL3del/del | K14 | OC, L, P | 40 | 3–4 | [48] |
PTENdel/del | K14 | OC | 100 | 1–2 | [49] |
miR-211 | K14 | T | n.a. | 3 | [50, 51] |
miR-31 | K14 | T | 80 | 3 | [52] |
Abbreviations: K14 keratin 14, OC oral cavity, T tongue, L larynx, P pharynx, n.a. not available